Toes RE - Search Results

1

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. Schoenberger SP, et al. Among authors: toes re. Nature. 1998 Jun 4;393(6684):480-3. doi: 10.1038/31002. Nature. 1998. PMID: 9624005

2

A rapid isolation procedure for dendritic cells from mouse spleen by centrifugal elutriation.

Ossevoort MA, Toes RE, De Bruijn ML, Melief CJ, Figdor CG, Kast WM. Ossevoort MA, et al. Among authors: toes re. J Immunol Methods. 1992 Oct 19;155(1):101-11. doi: 10.1016/0022-1759(92)90276-y. J Immunol Methods. 1992. PMID: 1328395 Free article.

3

An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene.

Toes RE, Offringa R, Blom RJ, Brandt RM, van der Eb AJ, Melief CJ, Kast WM. Toes RE, et al. J Immunol. 1995 Apr 1;154(7):3396-405. J Immunol. 1995. PMID: 7534797

4

Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.

Toes RE, Offringa R, Feltkamp MC, Visseren MJ, Schoenberger SP, Melief CJ, Kast WM. Toes RE, et al. Behring Inst Mitt. 1994 Jul;(94):72-86. Behring Inst Mitt. 1994. PMID: 7998917 Review.

5

The MHC expression of dendritic cells from mouse spleen isolated by centrifugal elutriation is upregulated during short term culture.

Ossevoort MA, Toes RE, De Bruijn ML, Melief CJ, Figdor CG, Kast WM. Ossevoort MA, et al. Among authors: toes re. Adv Exp Med Biol. 1993;329:185-9. doi: 10.1007/978-1-4615-2930-9_31. Adv Exp Med Biol. 1993. PMID: 8379369 No abstract available.

6

In vivo detection of fluorescent tumor-specific cytotoxic T cell clones.

Toes RE, den Haan JM, Feltkamp MC, Blom RJ, Melief CJ, Claassen E, Kast WM. Toes RE, et al. J Immunol Methods. 1993 Jul 6;163(1):23-32. doi: 10.1016/0022-1759(93)90235-y. J Immunol Methods. 1993. PMID: 8393053

7

Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization.

Feltkamp MC, Vierboom MP, Toes RE, Ossendorp F, ter Schegget J, Melief CJ, Kast WM. Feltkamp MC, et al. Among authors: toes re. Immunol Lett. 1995 Jul-Aug;47(1-2):1-8. doi: 10.1016/0165-2478(95)00052-7. Immunol Lett. 1995. PMID: 8537084

8

Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape.

Toes RE, Feltkamp MC, Ressing ME, Vierboom MP, Blom RJ, Brandt RM, Hartman M, Offringa R, Melief CJ, Kast WM. Toes RE, et al. Biochem Soc Trans. 1995 Aug;23(3):692-6. doi: 10.1042/bst0230692. Biochem Soc Trans. 1995. PMID: 8566445 Review. No abstract available.

9

Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors.

Toes RE, Blom RJ, Offringa R, Kast WM, Melief CJ. Toes RE, et al. J Immunol. 1996 May 15;156(10):3911-8. J Immunol. 1996. PMID: 8621930

10

Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hosts.

Toes RE, Kast WM, Blom RJ, Bakker SC, Offringa R, Melief CJ. Toes RE, et al. Int J Cancer. 1996 May 29;66(5):686-91. doi: 10.1002/(SICI)1097-0215(19960529)66:5<686::AID-IJC17>3.0.CO;2-2. Int J Cancer. 1996. PMID: 8647633 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results